Marshall Shaffer, Davi Sacco, George Colligan, Christian Atwood, Dave Gusella
January 24, 2026
Kirkland Advises Commure on Take-Private Acquisition of Augmedix

1 min
AI-made summary
- Commure, Inc., a General Catalyst portfolio company, has signed a definitive agreement to acquire Augmedix, Inc., a provider of ambient AI medical documentation and data solutions, in a take-private transaction
- The acquisition, announced on July 19, 2024, is expected to close in late Q3 or early Q4 of 2024
- Kirkland advised Commure on the deal, with a team led by corporate partner Marshall Shaffer.
Kirkland advised Commure, Inc., a General Catalyst portfolio company, on signing a definitive agreement for the take-private acquisition of Augmedix, Inc., a firm focused on ambient AI medical documentation and data solutions. Commure, Inc. will leverage synergies from the acquisition to continue to grow its platform in healthcare technology. The acquisition was announced July 19, 2024 and is scheduled to close in late Q3 or early Q4, 2024. Read the transaction press release The team was led by corporate partner Marshall Shaffer and associates Davi Sacco and George Colligan, with assistance from corporate partners Christian Atwood and Dave Gusella.
Article Author
Marshall Shaffer, Davi Sacco, George Colligan, Christian Atwood, Dave Gusella
The Sponsor
